Apuli Maricel 4

What Happened
Apuli Maricel, Chief Accounting Officer of BridgeBio (BBIO), disposed of a total of 4,859 shares in two transactions. On 2026-02-16, 4,349 shares were withheld to satisfy tax obligations related to the vesting of RSUs (withheld at $75.25/share, value $327,262). On 2026-02-17, she sold 510 shares in the open market at $74.31/share for $37,898. Total proceeds/values of the two dispositions are approximately $365,160. These were dispositions (sales/tax withholding), not purchases.

Key Details

• Transaction dates and prices:
  • 2026-02-16: 4,349 shares withheld for taxes at $75.25 — $327,262 (code F: tax withholding).
  • 2026-02-17: 510 shares sold open market at $74.31 — $37,898 (code S).
• Shares owned after transaction: Not disclosed in this filing.
• Footnotes of note:
  • F1: 4,349 shares were withheld to satisfy taxes on the vesting of 8,377 RSUs.
  • F2: The 510 shares sold include shares acquired Feb 13, 2026 via the company ESPP (exempt under Rule 16b‑3).
  • F3: The Feb 17 sale was effected under a Rule 10b5‑1 trading plan adopted Sept 8, 2025.
• Filing timeliness: Report filed 2026-02-18 for transactions on 2026-02-16 and 2026-02-17 — appears timely under Form 4 rules.

Context
Tax-withholding dispositions are a common cashless way to cover tax on vested RSUs and do not necessarily reflect a view on the company’s prospects. The open-market sale was executed under a pre-established 10b5‑1 plan, which typically schedules trades in advance. Purchases are generally more informative about insider sentiment; these transactions are routine dispositions and should be interpreted accordingly.